These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20567125)

  • 1. [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].
    Miyagawa K; Yata Y; Yamaoka N; Sagara Y
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1145-7. PubMed ID: 20567125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
    Takada J; Okuda K; Kenno S; Shimada S; Oba G; Shimokuni T; Aoki T; Hamada H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2120-2. PubMed ID: 19106543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced pancreatic cancer responding well to S-1/gemcitabine combination therapy after gemcitabine therapy].
    Kuji M; Yamamoto Y; Tani C; Kenno S; Kobayashi T
    Gan To Kagaku Ryoho; 2011 May; 38(5):853-5. PubMed ID: 21566453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
    Fukui H; Kou C; Matsumoto T; Matsumoto M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1775-8. PubMed ID: 20841945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
    Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent pancreatic cancer with lung metastasis responding to S-1 combined gemcitabine chemotherapy].
    Fukada I; Ikeda H; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Kawamoto K; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1733-6. PubMed ID: 19838037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of S-1/gemcitabine combination therapy for advanced pancreatic cancer].
    Hara T; Nagata M; Yamashita Y; Fujimoto K; Muraki Y; Yasuda Y; Kurahashi T
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1233-7. PubMed ID: 18633271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine].
    Akiyama N; Ayata S; Maruyama Y; Tsukada Y
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1591-3. PubMed ID: 20716894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of gemcitabine plus S-1 versus gemcitabine alone in cases with unresectable advanced pancreatic cancer.
    Suzuki S; Ozaki Y; Saida S; Kaji S; Koike N; Harada N; Hayashi T; Suzuki M
    Hepatogastroenterology; 2013 Jun; 60(124):916-20. PubMed ID: 23478143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases].
    Fukui H; Kou C; Fujioka M
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1727-31. PubMed ID: 23152029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer].
    Sasajima J; Tanno S; Koizumi K; Nakano Y; Habiro A; Chiba A; Fujii T; Sugiyama Y; Nakamura K; Nishikawa T; Mizukami Y; Okumura T; Kohgo Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1657-61. PubMed ID: 19838023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
    Nishimizu T; Minemura M; Kajiura S; Tokimitsu Y; Itaya Y; Yamawaki H; Kawai K; Tajiri K; Nakayama Y; Hosokawa A; Takahara T; Yasumura S; Shimizu S; Fukuoka J; Ishizawa S; Sawasaki T; Yanagisawa A; Sugiyama T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):309-12. PubMed ID: 21368502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical benefit of full-dose gemcitabine for advanced pancreatic cancer refractory to S-1+gemcitabine].
    Hachisuka H; Takahashi M; Kushima A; Nakamoto T; Takahashi K; Iwamura Y; Wakata M; Nagano K; Nakajima T; Nunomura M; Araki K
    Gan To Kagaku Ryoho; 2013 May; 40(5):639-42. PubMed ID: 23863590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
    Tokairin Y; Iida M; Yamazaki S
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2123-5. PubMed ID: 19106544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
    Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer.
    Kawashima H; Itoh A; Ohno E; Nakamura M; Miyahara R; Ohmiya N; Hara K; Kanamori A; Itoh T; Taki T; Hirai T; Hashimoto S; Takeda K; Goto H; Hirooka Y
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):677-83. PubMed ID: 21132496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer].
    Egawa T; Ohashi M; Ito Y; Mihara K; Takahashi T; Hayashi S; Nagashima A
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2422-4. PubMed ID: 20037443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine].
    Kawasaki H; Kukita K; Mizushima Y; Hirata K
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1239-42. PubMed ID: 18633272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer.
    Nakata B; Amano R; Nakao S; Tamura T; Shinto O; Hirakawa T; Okita Y; Yamada N; Hirakawa K
    J Exp Clin Cancer Res; 2010 Feb; 29(1):15. PubMed ID: 20181235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.